Advertisement

Topics

BD to invest $100m to expand insulin syringe manufacturing facility in US

01:15 EDT 23 Sep 2016 | Medical Business Review

Medical technology firm Becton, Dickinson and Company (BD) has unveiled plans to invest around $100m in its insulin syringe facility in the US.

Original Article: BD to invest $100m to expand insulin syringe manufacturing facility in US

NEXT ARTICLE

More From BioPortfolio on "BD to invest $100m to expand insulin syringe manufacturing facility in US"

Quick Search
Advertisement
 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...